• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug
28 February 2021

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug

In the Day of Rare Diseases, we want to share the excellent news of Orphan Drug designation by the EMA of the novel nanomedicine developed in Smart4Fabry project. This nanomedicine, based on peptide targeted nanoliposomes containing alpha-galactosidase A is formulated with our DELOS nanoformulation platform. Nanomol Technologies team has optimized, scaled-up and produced the required batches for regulatory preclinical testing using a Quality by Design approach. In the video below the project coordinator Nora Ventosa from CIBER-BBN and one of our founders summarizes this achievement.

Excellent results for an excellent international teamwork! INSTITUT DE CIÈNCIA DE MATERIALS DE BARCELONA (ICMAB-CSIC), CIBER-BBN, Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca, IQAC-CSIC, Leanbio, DDR drug Development and Regulation, Technion - Israel Institute of Technology, Aarhus University, Joanneum Research, BNN-Bionanonet, Biokeralty and Covance.

https://youtu.be/VSDkAVBrLA8

www.smart4fabry.eu

#pushingnanomedicinesforward #addingvaluetoyourmolecules

Related
news

Nanomol Technologies receives Crédit d’Impôt Recherche (CIR) accreditation by the French Ministry of Higher Education and Research 08 February 2021

Nanomol Technologies receives Crédit d’Impôt Recherche (CIR) accreditation by the French Ministry of Higher Education and Research

Nanomol Technologies is hiring a Process Engineer! 27 December 2022

Nanomol Technologies is hiring a Process Engineer!

Nanomol Technologies will participate in the 11th annual PODD 22 October 2021

Nanomol Technologies will participate in the 11th annual PODD

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2025

Nanomol Technologies S.L.

Site by Suki